Article

CMS Posts Stage 2 Clinical Quality Measures

Health information technology users, developers, and others wanting to review or comment on the clinical quality measures in the Stage 2 meaningful-use criteria have them now laid out in a handy, downloadable spreadsheet format.

Read the full story: http://hcp.lv/I3UO4B

Source: ModernHealthcare.com

The CMS posted the measures and descriptions about them—one sheet for hospitals and another sheet for office-based physicians and other eligible professionals—on its website.

Related Videos
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Parth Rali, MD
1 KOL is featured in this series.
4 KOLs are featured in this series
4 KOLs are featured in this series
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Related Content
AI illustration | Image Credit: Tierney - stock.adobe.com
October 7th 2024

Experts Highlight AI's Potential to Enhance ILD Diagnostic Accuracy Amid Limitations

Brooke McCormick
Experts at the CHEST 2024 annual meeting agreed that artificial intelligence (AI) should not be relied upon entirely, but instead be used as a tool by radiologists to make a diagnosis of interstitial lung disease (ILD).
Managed Care Cast
September 27th 2024

Frameworks for Advancing Health Equity: Community Wellness Centers

Giuliana Grossi
Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Air pollution | Image Credit: martin33 - stock.adobe.com
October 6th 2024

Air Pollution Increases IPF Exacerbations, but Role in Disease Progression Remains Uncertain

Brooke McCormick
Although air pollution is linked to increased exacerbations in patients with idiopathic pulmonary fibrosis (IPF), its role in disease progression remains uncertain, with evidence suggesting that both genetic susceptibility and environmental factors contribute to IPF development.
managed care cast logo
September 19th 2024

Exploring Consumer Perspectives on Network Adequacy Definitions

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the September 2024 issue of The American Journal of Managed Care® that explored the factors consumers consider essential for an adequate provider network.
COVID-19 virus | Image credit: phonlamaiphoto - stock.adobe.com
October 6th 2024

Predictors of Poor Outcomes in Patients With Myasthenia Gravis and COVID-19

Kimberly Rath, PharmD
Researchers identify certain predictive factors that impact the prognosis of patients with myasthenia gravis and COVID-19 infection.
Doctor consulting with patient | Image credit: ARMMY PICCA - stock.adobe.com
October 4th 2024

JAK Inhibitors Show Promise in Concurrent Myeloid Disorders, IADs

AJMC Contributor
In recent years, it’s been estimated that 10% to 28% of patients with myeloid disorders develop adult onset inflammatory and autoimmune disorders (IADs), complicating treatment.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo